Biohit Oyj - Managers' Transactions - Sorvo
Person subject to the notification requirement
Name: Jussi Sorvo
Position: Chief Financial Officer
Issuer: Biohit Oyj
LEI: 74370089ATTSNBXJVT29
Notification type: INITIAL NOTIFICATION
Reference number: 21886/4/6
____________________________________________
Transaction date: 2022-11-30
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: I 2021A
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 8000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 8000 Volume weighted average price: 0 EUR
____________________________________________
Transaction date: 2022-11-30
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: I 2021B
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 8000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 8000 Volume weighted average price: 0 EUR
____________________________________________
Transaction date: 2022-11-30
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: I 2021C
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 8000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 8000 Volume weighted average price: 0 EUR
____________________________________________
Transaction date: 2022-11-30
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: I 2021D
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 8000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 8000 Volume weighted average price: 0 EUR
____________________________________________
Transaction date: 2022-11-30
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: I 2021E
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 8000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 8000 Volume weighted average price: 0 EUR
____________________________________________
Transaction date: 2022-11-30
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: II 2021A
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 10000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 10000 Volume weighted average price: 0 EUR
____________________________________________
Transaction date: 2022-11-30
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: II 2021B
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 10000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 10000 Volume weighted average price: 0 EUR
____________________________________________
Transaction date: 2022-11-30
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: II 2021C
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 10000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 10000 Volume weighted average price: 0 EUR
____________________________________________
Transaction date: 2022-11-30
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: II 2021D
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 10000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 10000 Volume weighted average price: 0 EUR
Additional information:
investor.relations@biohit.fi
www.biohithealthcare.com